EXAS vs QTRX · rev $2.76B vs rev $69.3M
EXACT Sciences Corporation (EXAS) versus Quanterix Corp (QTRX) — a side-by-side from cached financials, not a winner call.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Quanterix Corp (QTRX) is a medical devices company listed on US.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
Latest reported QTRX revenue for 2026-06-30 was $69.3M. Net income was -$66.5M. Revenue was up 90.4% from 2026-03-31 to 2026-06-30. QTRX currently screens at market cap $274.8M.
EXAS currently screens at market cap $20.03B. QTRX currently screens at market cap $274.8M.
Not investment advice. Open the EXAS and QTRX stock pages for the full models.
Not investment advice.